Document is current

Article History

Received: 31 May 2024

Accepted: 23 September 2024

First Online: 4 October 2024

Declarations

:

: This study received approval by The Swedish Ethical Review Authority, no 2020–02360. All participants privded written informed consent to participate in the study. Patients are recruited from diverse psychiatric healthcare settings, including psychiatric and emergency care, consultation psychiatry, inpatient psychiatric wards, and outpatient psychiatric care in Sweden. Those meeting the specified eligibility criteria (see below) are invited to participate in an initial visit. Ahead of the first visit, patients are provided with written information delineating the research project’s purpose, followed by a verbal description of its implications. Written consent is then obtained from the patient, who retains the prerogative to withdraw from the study at any juncture without the obligation to provide a specific reason.Any significant modifications to the study protocol, such as changes to eligibility criteria, study outcomes, or analysis methods, will be formally documented and communicated to all relevant parties. This includes the research team, ethics committee, trial registries, and any regulatory authorities involved in the oversight of the trial.

: Not applicable.

: The authors declare no competing interests.